Research
Clinical trials
Every amyloidosis study now recruiting, about to open, or enrolling by invitation, anywhere in the world, listed straight from ClinicalTrials.gov and refreshed every day.
Information, not medical advice. The Alliance does not run these studies and cannot enrol you in one. If a trial looks relevant, discuss it with the doctor who follows your amyloidosis.
Recruiting and upcoming studies
The list covers AL, ATTR and AA amyloidosis as well as cerebral amyloid angiopathy. Each card says where the study stands: open to anyone who meets its criteria, not yet open, or restricted to people the investigators invite. Studies that close simply leave the list.
Showing 85–96 of 208 trials
RecruitingNot specified
Dietary Reporting In The Amyloidoses (opens on ClinicalTrials.gov)
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to…
- Study
- Interventional (treatment)
- Sponsor
- Barbara Ann Karmanos Cancer Institute
Recruiting in: United States
NCT05738005Updated 26 June 2026
RecruitingCerebral amyloid angiopathy
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy (opens on ClinicalTrials.gov)
Cerebral hemorrhage, as a serious cerebrovascular disease, has the highest disability rate and mortality rate among all types of cerebrovascular diseases .It has brought…
- Study
- Interventional (treatment)
- Phase
- Phase 3
- Sponsor
- Beijing Tiantan Hospital
Recruiting in: China
NCT07250035Updated 24 June 2026
RecruitingNot specified
Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy (opens on ClinicalTrials.gov)
This study aims to evaluate the safety and effectiveness of Enavogliflozin 0.3 mg, an SGLT2 inhibitor, in patients with amyloid cardiomyopathy. Participants will take…
- Study
- Interventional (treatment)
- Phase
- Phase 4
- Sponsor
- Seoul St. Mary's Hospital
Recruiting in: South Korea
NCT07240844Updated 18 June 2026
RecruitingAL (light chain)
Evaluation of Skin Tests in Biotherapy Allergies (opens on ClinicalTrials.gov)
Biotherapies are biological (extracted from an organism or living tissue) or biotechnological drugs used in the treatment of multiple conditions, such as autoimmune inflammatory…
- Study
- Interventional (treatment)
- Sponsor
- University Hospital, Angers
Recruiting in: France
NCT06971848Updated 18 June 2026
RecruitingATTR (transthyretin)
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY (opens on ClinicalTrials.gov)
Cardiac amyloidosis is a condition where the heart muscle, amongst other tissues, is infiltrated by the abnormal build-up of proteins called amyloid. This stiffens…
- Study
- Interventional (treatment)
- Sponsor
- Richmond Research Institute
Recruiting in: United Kingdom
NCT05098665Updated 16 June 2026
RecruitingNot specified
Using Light Therapy for Mild Cognitive Impairment (opens on ClinicalTrials.gov)
The goal of this clinical trial is to test whether transcranial photobiomodulation (tPBM), a non-invasive brain stimulation technique using near-infrared light, can improve brain…
- Study
- Interventional (treatment)
- Sponsor
- University of Oklahoma
Recruiting in: United States
NCT07651787Updated 16 June 2026
Not yet recruitingNot specified
AI-based Echocardiography for Detection of Cardiac Amyloidosis (opens on ClinicalTrials.gov)
Cardiac amyloidosis is characterized by deposition of misfolded protein in the myocardium causing mainly heart failure symptoms with preserved left ventricular ejection fraction. There…
- Study
- Interventional (treatment)
- Sponsor
- Germans Trias i Pujol Hospital
No study locations listed yet
NCT07529860Updated 12 June 2026
RecruitingATTR (transthyretin)
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy (opens on ClinicalTrials.gov)
Transthyretin amyloidosis (ATTR) is an underdiagnosed condition that can present early as carpal tunnel syndrome, sometimes preceding cardiac involvement by several years. The recent…
- Study
- Interventional (treatment)
- Sponsor
- Clinique Saint Jean, France
Recruiting in: France
NCT07644325Updated 12 June 2026
RecruitingATTR (transthyretin)
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis (opens on ClinicalTrials.gov)
Primary objective: To identify older adults with transthyretin cardiac amyloidosis (ATTR-CA) early in the course of the illness, at a time when disease modifying…
- Study
- Observational (registry, imaging)
- Sponsor
- Columbia University
Recruiting in: United States
NCT06034405Updated 4 June 2026
RecruitingAL (light chain)
Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis (opens on ClinicalTrials.gov)
Systemic light chain amyloidosis (AL amyloidosis) is the most common type of systemic amyloidosis, with diverse clinical manifestations and difficulties in diagnosis and treatment.…
- Study
- Interventional (treatment)
- Phase
- Early phase 1
- Sponsor
- Beijing Boren Hospital
Recruiting in: China
NCT07626476Updated 4 June 2026
Not yet recruitingAL (light chain)
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging (opens on ClinicalTrials.gov)
The goal of this clinical trial is to evaluate whether ¹⁸F-florbetaben PET/MR can detect systemic amyloid deposits early and noninvasively in patients with monoclonal…
- Study
- Interventional (treatment)
- Sponsor
- University of Zurich
Recruiting in: Switzerland
NCT07624760Updated 3 June 2026
RecruitingATTR (transthyretin)
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) (opens on ClinicalTrials.gov)
The goal of this clinical trial is to test the effects of the inotropic drug named dobutamine, in patients with wild-type Transthyretin Amyloid Cardiomyopathy…
- Study
- Interventional (treatment)
- Phase
- Phase 1
- Sponsor
- Steen Hvitfeldt Poulsen
Recruiting in: Denmark
NCT06318260Updated 1 June 2026
This list only covers amyloidosis studies that are open or about to open. The registry holds every study, including those already completed.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). List last retrieved on 25 September 2026. clinicaltrials.gov
Not sure where to start?
Our member associations know the teams running these studies in their own country, and can help you prepare the conversation with your doctor.